Emirgency

Has patented a diagnostic technology based on multi-dosing of circulating miRNAs by electrochemistry in microfluidics, combining magnetic hyperthermia and electrochemical detection for rapid, sensitive and multiplexed analysis, facilitating early cancer detection with increased accuracy and reduced cost.